[Federal Register Volume 67, Number 16 (Thursday, January 24, 2002)]
[Notices]
[Pages 3503-3504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-1798]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material,

[[Page 3504]]

and personal information concerning individuals associated with the 
contract proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Drug Development for Opportunistic 
Infections--Hepatitis C.
    Date: February 28--March 1, 2002.
    Time: February 28, 2002, 8:30 AM to adjournment.
    Agenda: To review and evaluate contract proposals.
    Place: 2 Montgomery Village Avenue, Gaithersburg, MD 20879.
    Contact Person: Gregory P. Jarosik, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID, 6700B Rockledge Drive, NMSC-7617, Bethesda, MD 
20892, 301-496-2550, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


    Dated: January 17, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-1798 Filed 1-23-02; 8:45 am]
BILLING CODE 4140-01-M